Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
NCT00374322
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3166
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Breast
Interventions
DRUG:
lapatinib
OTHER:
placebo
Sponsor
GlaxoSmithKline